CLOVER HEALTH INVESTMENTS, CORP. /DE

Clover Health Investments, Corp. reported a significant financial turnaround for Q2 2026, achieving a net income of $28.0 million compared to a net loss of $10.6 million in Q2 2025. Total revenues surged by 55.6% to $743.2 million. For the six months ended June 30, 2026, the company also posted a net income of $55.3 million, a substantial improvement from a $11.9 million net loss in the prior year period. The company also highlighted the strategic launch of Counterpart Health, Inc. in 2024, aiming to expand its Clover Assistant technology to external payors and providers.

Clover Health reported strong second quarter 2026 financial results, achieving a GAAP Net Income of $28 million, a $39 million improvement year-over-year. The company saw significant growth with total revenues up 56% to $743 million and Medicare Advantage membership increasing 48% to 157,309. Building on this performance, Clover Health raised its full-year 2026 guidance across all key metrics, including total revenues, consolidated gross profit, Adjusted EBITDA, and GAAP Net Income, citing strengthening business performance and an increasing confidence for 2027.

Clover Health announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Canaccord Genuity 46th Annual Growth Conference. The presentation is scheduled for Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time. A live webcast and replay will be accessible on the company's investor relations website.

Clover Health Investments, Corp. reported a cybersecurity incident discovered on July 4, 2026, involving anomalous login activity. An investigation revealed that a threat actor gained access to three non-managerial health plan employee accounts via social engineering, which had access to personally identifiable and protected health information, but not corporate financial systems. The company believes its rapid response contained the unauthorized access and does not anticipate a material impact on its business, financial condition, or results of operations. Clover Health is continuing its investigation and plans to make all required regulatory and member notifications.

Clover Health Investments, Corp. announced it will release its second quarter 2026 financial results after the market closes on Wednesday, August 5, 2026. The company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss its business and financial performance. A live and archived webcast will be accessible from the Investor Relations section of Clover Health’s website.

Clover Health's subsidiary, Counterpart Health, released a whitepaper detailing the positive impact of its AI-powered Counterpart Assistant (CA) platform. The analysis showed that CA significantly improves post-hospitalization follow-up and performance on key HEDIS quality measures. Specifically, CA-enabled primary care physicians achieved a 33% higher rate of discharge information receipt and an 11% higher rate of medication reconciliation. Counterpart Assistant is now commercially available to other healthcare organizations.

Clover Health Investments, Corp. announced that the Centers for Medicare & Medicaid Services (CMS) recalculated its 2026 Star Ratings for two Medicare Advantage contracts. The PPO contract (H5141) rating increased from 3.5 to 4.5 Stars, and the HMO contract (H8010) rating increased from 4.0 to 4.5 Stars, both impacting payment year 2027. This recalculation by CMS for 2027 Quality Bonus Payment ratings followed a court judgment.

Clover Health Investments, Corp. announced that Brady Priest will step down from his role as Chief Executive Officer of Clover Care Services, the company's home-care business, effective July 3, 2026. The company has decided not to appoint a successor, opting instead to reorganize and allocate Mr. Priest's former responsibilities among its existing executive leadership team. This strategic move is intended to more closely integrate Clover Care Services with Clover Health's broader operations, and Mr. Priest's departure was not due to any disagreement with the company.

Clover Health Investments, Corp. announced that the United States District Court for the Southern District of Georgia granted summary judgment in part for its subsidiary, Clover Insurance Company, regarding its 2026 Star Rating. Following the court's order to recalculate, the Centers for Medicare & Medicaid Services (CMS) informed Clover that its 2026 Star Rating for Contract H5141, covering over 97% of its members, has been revised from 3.5 Stars to 4.5 Stars. This improved rating impacts Payment Year 2027, while the HMO plan's 4.0 Star Rating remains unchanged.

Clover Health Investments, Corp. published a supplemental Q&A providing further insights into its first quarter 2026 performance and business outlook. The company highlighted the impact of Clover Assistant on medical cost trends, the growth of Clover Care Services, and its strategy to prioritize member integration over rapid in-year growth. Clover Health reiterated its goal for GAAP profitability in 2026, driven by cohort maturation and improved care, and discussed the expansion opportunities in core markets like New Jersey and through Counterpart Health.